TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 7.498 million compared to TWD 4.149 million a year ago. Net loss was TWD 102.936 million compared to net income of TWD 60.454 million a year ago. Basic loss per share was TWD 0.14 compared to basic earnings per share of TWD 0.08 a year ago. Diluted eps was TWD 0 compared to TWD 0.08 a year ago. For the half year, sales was TWD 10.819 million compared to TWD 8.698 million a year ago. Net loss was TWD 175.113 million compared to net income of TWD 6.375 million a year ago. Basic loss per share was TWD 0.24 compared to basic earnings per share of TWD 0.01 a year ago. Diluted eps was TWD 0 compared to TWD 0.01 a year ago.